BamSEC and AlphaSense Join Forces
Learn More

PLUS THERAPEUTICS Inc.

NASDAQ: PSTV    
Share price (11/21/24): $1.20    
Market cap (11/21/24): $7.076 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.10
from 10-Q 2 pages Certificate of Elimination of Series F Preferred Stock of PLUS Therapeutics, Inc. Pursuant to Section 151(g) of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Amended and Restated Certificate of Incorporation of Plus Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 3 pages Plus Therapeutics, Inc. Certificate of Designation of Series F Preferred Stock Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.2
from 8-K 2 pages Certificate of Elimination of the Series a 3.6% Convertible Preferred Stock of Plus Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 27 pages Amended and Restated Bylaws of Plus Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Amended and Restated Certificate of Incorporation of Plus Therapeutics, Inc
12/34/56
EX-3.2
from 8-K 15 pages Amended and Restated Bylaws of Plus Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment of Amended and Restated Certificate of Incorporation of Cytori Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 20 pages Cytori Therapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law Terms of Preferred Stock
12/34/56
EX-3
from POS AM 20 pages Cytori Therapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law Terms of Preferred Stock
12/34/56
EX-3
from S-1/A 15 pages Cytori Therapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law Terms of Preferred Stock
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Amended and Restated Certificate of Incorporation of Cytori Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 14 pages Cytori Therapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law Terms of Preferred Stock
12/34/56
EX-3
from S-1/A 14 pages Cytori Therapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law Terms of Preferred Stock
12/34/56
EX-3
from S-1/A 17 pages Cytori Therapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law Terms of Preferred Stock
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Amended and Restated Certificate of Incorporation of Cytori Therapeutics, Inc
12/34/56
EX-3.1
from 10-K 2 pages Composite Certificate of Incorporation of Cytori Therapeutics, Inc
12/34/56
EX-3.1
from 10-K 2 pages Composite Certificate of Incorporation of Cytori Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 29 pages Cytori Therapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a 3.6% Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law 1 Terms of Preferred Stock
12/34/56
EX-3.1
from 8-K 2 pages Amendment to the Amended and Restated Bylaws of Cytori Therapeutics, Inc
12/34/56